Michael Kreiberg
Papers
1
Total Citations
14
H-Index
1
About
Michael Kreiberg is a clinical researcher whose work centers on the surgical management of testicular cancer, specifically non-seminomatous germ cell tumours (NSGCT). His major contribution is a systematic review examining oncological outcomes and complications following post-chemotherapy retroperitoneal lymph node dissection (RPLND), a critical procedure for patients with residual retroperitoneal masses. This work, which has garnered 14 citations, provides a comprehensive synthesis of recurrence rates and surgical morbidity, offering evidence-based guidance for urologists and oncologists navigating this high-stakes intervention. By clarifying the risks and benefits of bilateral RPLND, Kreiberg’s research directly informs clinical decision-making in a field where balancing cancer control with surgical complications is paramount. His findings are particularly valuable for trainees and specialists seeking to optimize outcomes in this challenging patient population. Through this systematic review, Kreiberg has established himself as a thoughtful contributor to the evidence base in testicular cancer surgery, helping to refine protocols that improve both survival and quality of life for survivors.
Research Focus
Key Achievements
Top Papers
- 1